PISANU, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 125.524
NA - Nord America 4.332
AS - Asia 783
OC - Oceania 18
AF - Africa 11
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 130.680
Nazione #
IT - Italia 124.569
US - Stati Uniti d'America 4.297
CN - Cina 466
SE - Svezia 335
SG - Singapore 144
DE - Germania 139
UA - Ucraina 126
GB - Regno Unito 99
FI - Finlandia 81
VN - Vietnam 60
NL - Olanda 52
IN - India 31
CA - Canada 28
ES - Italia 28
KR - Corea 24
FR - Francia 23
BE - Belgio 20
AU - Australia 16
RU - Federazione Russa 15
HK - Hong Kong 13
IR - Iran 12
CZ - Repubblica Ceca 10
IE - Irlanda 10
JP - Giappone 10
TR - Turchia 8
MX - Messico 7
BR - Brasile 5
CH - Svizzera 4
IL - Israele 4
CI - Costa d'Avorio 3
CL - Cile 3
MY - Malesia 3
PK - Pakistan 3
PT - Portogallo 3
TW - Taiwan 3
AR - Argentina 2
DK - Danimarca 2
EG - Egitto 2
ID - Indonesia 2
MA - Marocco 2
MG - Madagascar 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
ZA - Sudafrica 2
BG - Bulgaria 1
CO - Colombia 1
EU - Europa 1
IS - Islanda 1
MK - Macedonia 1
RO - Romania 1
Totale 130.680
Città #
Cagliari 124.223
Fairfield 721
Chandler 379
Woodbridge 340
Ashburn 324
Houston 299
Seattle 276
Nyköping 260
Wilmington 220
Cambridge 217
New York 195
Ann Arbor 177
Shanghai 107
Dearborn 88
Boardman 86
Jacksonville 69
Boston 65
Helsinki 63
Dong Ket 60
Beijing 59
Singapore 45
San Diego 39
Nanjing 33
Rome 28
Redwood City 27
London 26
Seoul 22
Norwalk 21
Atlanta 18
Guangzhou 18
Los Angeles 18
Nanchang 17
Brussels 16
Aurora 15
Shenyang 15
Milan 14
Jiaxing 13
Pune 13
San Francisco 13
Rotterdam 12
San Mateo 11
Toronto 11
Brno 10
Changsha 10
Barendrecht 9
Falls Church 9
Hebei 9
Orange 9
Shenzhen 9
Iowa City 8
Mountain View 8
Washington 8
Wuhan 8
Ardabil 7
Hangzhou 7
Hefei 7
Kunming 7
Oristano 7
Williamstown 7
Zhengzhou 7
Boydton 6
Jinan 6
Motril 6
Sassari 6
Serramanna 6
Shaoxing 6
Tianjin 6
Amersfoort 5
Chengdu 5
Dublin 5
Nuremberg 5
Phoenix 5
Richmond 5
Rochester 5
Suni 5
Adelaide 4
Amsterdam 4
Baoding 4
Chicago 4
Council Bluffs 4
Edmonton 4
Hong Kong 4
Hyderabad 4
Konya 4
Las Vegas 4
Leawood 4
Naples 4
Olbia 4
Ozieri 4
Paris 4
Quartu Sant'Elena 4
Redmond 4
Selargius 4
Southwark 4
Sydney 4
Tokyo 4
Zacatecas City 4
Abidjan 3
Augusta 3
Berlin 3
Totale 128.998
Nome #
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.069
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 3.589
Odor identification performance in idiopathic Parkinson’s disease is associated with gender and the genetic variability of the olfactory binding protein 3.232
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.035
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 2.876
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 2.811
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity 2.774
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 2.727
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 2.716
Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study 2.711
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 2.671
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.660
Challenges and Future Prospects of Precision Medicine in Psychiatry 2.630
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 2.582
HDAC3 role in medication consumption in medication overuse headache patients: a pilot study 2.496
Involvement of core clock genes in lithium response 2.483
Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations 2.471
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.424
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics 2.416
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.367
Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database. 2.309
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.177
Pharmacogenomics of bipolar disorder 2.173
Prediction of Lithium Response using Clinical Data 2.170
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample 2.170
null 2.132
Sex differences in the response to opioids for pain relief: A systematic review and meta-analysis 2.088
High leptin levels are associated with migraine with aura 2.074
Lithium pharmacogenetics: Where do we stand? 2.069
Increasing engagement in pharmacology and pharmacogenetics education using games and online resources: the PharmacoloGenius mobile app 2.064
Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres? 2.005
Thyroid and renal tumors in patients treated with long-term lithium: case series from a lithium clinic, review of the literature and international pharmacovigilance reports 1.927
Efficacia dei farmaci per l’alcolismo: il ruolo della genetica 1.802
An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes 1.791
Lithium pharmacogenetics 1.725
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.713
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.609
null 1.572
Zinc finger proteins in psychiatric disorders and response to psychotropic medications 1.541
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 1.484
A genetic risk score is differentially associated with migraine with and without aura 1.482
Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches 1.431
Leukocyte telomere length is reduced in patients with major depressive disorder 1.383
We are not alone in our body: insights into the involvement of microbiota in the etiopathogenesis and pharmacology of mental illness 1.376
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI 1.304
Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment 1.293
PharmacoloGenius: Development of a mobile application to engage in pharmacology 1.281
Characterisation of age and polarity at onset in bipolar disorder 1.232
Prediction of lithium response using genomic data 1.200
null 1.156
Telomere length in bipolar disorder and lithium response 1.149
Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review 1.105
Assessment of the pharmacogenomics educational environment in southeast europe 1.051
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine 1.045
A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants 1.043
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 911
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 778
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders 660
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 638
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study 627
Gender Differences among Sardinians with Alcohol Use Disorder 618
The Xs and Y response to opioids in acute and chronic pain 616
Sex differences in alcohol use disorder 540
Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients 517
Sex differences in substance use disorders: focus on side effects 509
Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank 493
Involvement of gut microbiota in schizophrenia and treatment resistance to antipsychotics 492
Is Poor Lithium Response in Individuals with Bipolar Disorder Associated with Increased Degradation of Tryptophan along the Kynurenine Pathway? Results of an Exploratory Study 470
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 468
A genome-wide association study of antidepressant-induced mania 410
Investigating the role of leukocyte telomere length in treatment-resistant depression and in response to electroconvulsive therapy 400
Cost–utility analysis of pharmacogenetic testing based on CYP2C19 or CYP2D6 in major depressive disorder: assessing the drivers of different cost-effectiveness levels from an Italian societal perspective 396
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review 396
Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders 394
Genetic and Epigenetic Markers of Lithium Response 377
Summaries of plenary, symposia, and oral sessions at the XXII World Congress of Psychiatric Genetics, Copenhagen, Denmark, 12-16 October 2014 369
Investigating Shared Genetic Bases between Psychiatric Disorders, Cardiometabolic and Sleep Traits Using K-Means Clustering and Local Genetic Correlation Analysis 362
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 351
Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder 347
Migraine and gastrointestinal disorders in middle and old age: A UK Biobank study 345
Probing the Association between Cognition, Suicidal Behavior and Tryptophan Metabolism in a Sample of Individuals Living with Bipolar Disorder: A Secondary Analysis 339
Plasma stearoyl-coA desaturase activity indices and bile acid concentrations after a low-fat meal: Association with a genetic variant in the FTO gene 338
An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response 311
High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis 311
Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept 291
Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review 290
Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder 286
An analysis-ready and quality controlled resource for pediatric brain white-matter research 276
Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment 270
Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach 253
Effect of Lithium on gene expression modulation 253
NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition 250
Towards precision medicine in psychiatry: investigating the contribution of cellular aging, pleiotropy and gender differences in psychiatric disorders and pharmacological response 245
New insights into the genetic etiology of Alzheimer's disease and related dementias 245
Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients (Translational Psychiatry, (2021), 11, 1, (606), 10.1038/s41398-021-01702-2) 245
Anxiety Disorders are Associated with Low Socioeconomic Status in Women but Not in Men 230
Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets 207
Application of Support Vector Machine on fMRI Data as Biomarkers in Schizophrenia Diagnosis: A Systematic Review 167
Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study 143
Erratum: Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: Machine learning approach (The British Journal of Psychiatry (2022) (1–10) DOI: 10.1192/bjp.2022.28) 142
Totale 130.442
Categoria #
all - tutte 158.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.714


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020.483 0 582 143 285 7.429 5.518 3.320 658 517 552 534 945
2020/202141.400 1.143 1.583 1.586 11.112 7.453 4.698 2.682 2.666 1.377 2.741 2.720 1.639
2021/202210.999 1.450 652 510 1.016 990 707 574 508 1.262 1.197 1.204 929
2022/202316.802 960 2.313 2.452 1.529 1.304 1.617 848 1.042 1.211 1.248 1.470 808
2023/202416.375 770 611 612 1.037 1.419 2.565 2.311 1.197 835 1.075 1.958 1.985
2024/202511.114 10.322 792 0 0 0 0 0 0 0 0 0 0
Totale 131.164